Last update :
21/10/2020
Summary lists   Summary lists  

This page permits the cross-consultation of the stability information.

Stability in solutions
Factors which affect stability
Incompatibilities
Route of administration
Route of administration
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y -      Pdf
Compound Container Solvent Concentration Temperature Storage Length of time References
Injection Ciprofloxacin lactate Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 20°C Protect from light
42 Day
2368
Injection Ciprofloxacin lactate Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 37°C Protect from light
42 Day
2368
Injection Ciprofloxacin lactate Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 4°C Protect from light
42 Day
2368
Injection Moxifloxacin Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0.025 mg/ml 25°C Not specified
7 Day
2145
Injection Moxifloxacin Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0.025 mg/ml 37°C Not specified
3 Day
2145
Injection Moxifloxacin Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0.025 mg/ml 4°C Not specified
14 Day
2145
Injection Vancomycin hydrochloride Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 20°C
28 Day
2370
Injection Vancomycin hydrochloride Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 37°C
7 Day
2370
Injection Vancomycin hydrochloride Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0,025 mg/ml 4°C Not specified
28 Day
2370

  Mentions Légales